Mylan recalls 2 drugs after label mix-up

The drugmaker has not received any reports of adverse occasions.

© Copyright ASC COMMUNICATIONS 2020. Intrigued in LINKING to or REPRINTING this material? View our policies by clicking here.

Mylan has remembered 2 of its drugs after learning of a carton label mix-up, according to an Aug. 31 FDA statement.

Both medications are administered by health care specialists in medical facility or center settings. Mylan is notifying its wholesalers and health center drug stores of the recall by letter.

Katie Adams –
Tuesday, September 1st, 2020

The Canonsburg, Pa.-based drugmaker remembered 4 great deals of amiodarone HCl injection, which deals with heart rhythm issues, and tranexamic acid injection, which promotes blood clotting.

More short articles on pharmacy: FDA extends remdesivirs emergency use authorization to all hospitalized COVID-19 patientsWalgreens names former Rite Aid CEO as its new president78% of Americans think vaccine approval procedure is too politics-driven.